Patents Assigned to Tylerton International Inc.
  • Patent number: 10646183
    Abstract: A method of tissue recognition of tissue type in a heart or other tissue, comprising: (i) injecting a patient with a radioactive tracer; (ii) collecting radiation emitted from cardiac tissue (iii) associating said collected radiation with a wall of the heart; and (iv) analyzing said associated radiation to recognize fibrous tissue in the heart wall. Optionally, the resolution of the association is better than 5 mm.
    Type: Grant
    Filed: January 8, 2015
    Date of Patent: May 12, 2020
    Assignee: Tylerton International Inc.
    Inventor: Shlomo Ben-Haim
  • Patent number: 10493294
    Abstract: A method of treating cardiac arrhythmia in a heart, including (i) determining that cardiac tissue is viable but with reduced innervation; and (ii) ablating the tissue to reduce a prevalence of arrhythmia in said heart. Optionally, the determining comprises detecting portions of heart wall which lack electrical activity. Optionally, at least some tissue which is viable but lacks nervous control is ablated, for example, to reduce or avoid arrhythmia.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: December 3, 2019
    Assignee: Tylerton International Inc.
    Inventor: Shlomo Ben-Haim
  • Publication number: 20180280713
    Abstract: A method of treating cardiac arrhythmia in a heart, including (i) determining that cardiac tissue is viable but with reduced innervation; and (ii) ablating the tissue to reduce a prevalence of arrhythmia in said heart. Optionally, the determining comprises detecting portions of heart wall which lack electrical activity. Optionally, at least some tissue which is viable but lacks nervous control is ablated, for example, to reduce or avoid arrhythmia.
    Type: Application
    Filed: June 6, 2018
    Publication date: October 4, 2018
    Applicant: Tylerton International Inc.
    Inventor: Shlomo BEN-HAIM
  • Patent number: 10052495
    Abstract: A method of treating cardiac arrhythmia in a heart, including (i) determining that cardiac tissue is viable but with reduced innervation; and (ii) ablating the tissue to reduce a prevalence of arrhythmia in said heart. Optionally, the determining comprises detecting portions of heart wall which lack electrical activity. Optionally, at least some tissue which is viable but lacks nervous control is ablated, for example, to reduce or avoid arrhythmia.
    Type: Grant
    Filed: September 8, 2014
    Date of Patent: August 21, 2018
    Assignee: Tylerton International Inc.
    Inventor: Shlomo Ben-Haim
  • Publication number: 20170246465
    Abstract: Methods and devices for tying management of an implantable medical device to the activities of a primary care physician are described, including access control, simplified parameter optimization, support for tuning a device in response to the effects of other treatments in parallel, and support for helping a primary physician and a patient work together to tune device configuration to the activity and performance needs of the patient. In some embodiments, a medical device is self-configuring in a device parameter domain, based on inputs provided in a patient performance domain. The self-configuring of the medical device is based, for example, on an automatically applied transformation of inputs derived from patient performance domain observations into changes in the configuration of the medical device which affect technical parameters of its operation.
    Type: Application
    Filed: June 23, 2016
    Publication date: August 31, 2017
    Applicant: Tylerton International Inc.
    Inventors: Shlomo Ben-Haim, David Prutchi, Yuval Ben-Haim
  • Publication number: 20160217571
    Abstract: A method of treating cardiac arrhythmia in a heart, including (i) determining that cardiac tissue is viable but with reduced innervation; and (ii) ablating the tissue to reduce a prevalence of arrhythmia in said heart. Optionally, the determining comprises detecting portions of heart wall which lack electrical activity. Optionally, at least some tissue which is viable but lacks nervous control is ablated, for example, to reduce or avoid arrhythmia.
    Type: Application
    Filed: September 8, 2014
    Publication date: July 28, 2016
    Applicant: Tylerton International Inc.
    Inventor: Shlomo BEN-HAIM
  • Publication number: 20090312676
    Abstract: A method for increasing metabolism of a subject's body in order to lose weight, comprising: a) contacting a part of the body with a cooling element to remove heat from the body; and b) repeating or continuing (a) so as to remove enough heat in total to lose at least 1 kilogram of body weight.
    Type: Application
    Filed: February 1, 2007
    Publication date: December 17, 2009
    Applicant: Tylerton International Inc.
    Inventors: Benny Rousso, Shlomo Ben-Haim, Yoram Izhaki, Omer Einav
  • Publication number: 20090098198
    Abstract: A capsule for suppressing appetite, comprising: a) a shell which dissolves in the stomach; and b) a plurality of elements inside the shell, which elements expand inside the stomach, after the shell dissolves, to form a connected mass with an envelope volume greater than the total volume of the elements, and at least 3 times the volume of the capsule.
    Type: Application
    Filed: August 9, 2006
    Publication date: April 16, 2009
    Applicant: Tylerton International Inc.
    Inventors: Benny Rousso, Shlomo Ben-Haim
  • Publication number: 20080132383
    Abstract: A wellness apparatus, comprising: at least one support for a body portion of a user of the apparatus; at least one robotic actuator adapted to move the body portion; and a controller configured to control the actuator in accordance with needs of the user for physical exercise, the controller also adapted for assisting the user with primarily non-physical exercise activity.
    Type: Application
    Filed: December 7, 2005
    Publication date: June 5, 2008
    Applicant: Tylerton International Inc.
    Inventors: Omer Einav, Haim Einav, Richard M. Mahoney
  • Publication number: 20080033518
    Abstract: A thermoregulating unit for increasing metabolism of at least a portion of a human body, the thermoregulating unit comprises a support surface configured for supporting at least a portion of a human body, and at least one thermoregulating chamber juxtaposed on said support surface, said at least one thermoregulating chamber configured to draw heat away from said at least a portion of the human body supported on said support surface.
    Type: Application
    Filed: August 2, 2007
    Publication date: February 7, 2008
    Applicant: Tylerton International Inc.
    Inventors: Benny Rousso, Yoram Izhaki, Or Shabtay